Cell-type-resolved colocalisation prioritises KCNIP2 as a candidate epilepsy drug-target detectable at inhibitory-neuron but not bulk-tissue resolution: a Mendelian randomisation and colocalisation study
Front Genet. 2026 Oct 14;17:1920945. doi: 10.3389/fgene.2026.1920945.
Article
Oct 28, 2026
Consortium publication
No